StockData

InfuSystem vs OraSure Technologies

INFU and OSUR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INFU and OSUR compare

InfuSystem is the larger company, worth 1.2 times as much as OraSure Technologies ($295M against $242M).

InfuSystem grew revenue faster over the last twelve months (2.5% versus −18.9% for OraSure Technologies).

InfuSystem keeps more of each dollar of sales as profit, with a net margin of 6.0% compared with −43.7% at OraSure Technologies.

InfuSystem scores higher on the StockData Score (13 against 11 for OraSure Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINFUOSUR
Size and price
Market cap$295M$242M
Share price$14.79$3.51
Change, 1 year55.5%51.9%
Change, 5 years−13.4%−63.2%
Beta (5Y)0.841.27
Employees473500
StockData Score
Total score13 (better)11
Valuation score13 (better)
Growth score2 (better)1
Performance score4 (better)1
Health score66
Dividend score00
Valuation
P/E36.1×–
P/S2.1× (better)2.2×
P/B5.0×0.8× (better)
EV/EBITDA11.9×–
P/FCF12.9×–
FCF yield7.8% (better)−19.9%
Fair value$14.49$5.54
Margin of safety−2.1%36.6% (better)
Growth
Revenue growth (TTM)2.5% (better)−18.9%
Revenue growth, 5Y average8.1% (better)−7.7%
Net income growth (TTM)68.4%–
EPS growth (TTM)78.3%–
EPS growth, 5Y average−17.3%–
Profitability
Gross margin57.5% (better)42.6%
Operating margin9.3% (better)−48.1%
Net margin6.0% (better)−43.7%
FCF margin16.0% (better)−42.8%
Return on equity15.0% (better)−14.1%
Return on invested capital11.7% (better)−28.1%
Financial health
Debt / equity0.35 (better)0.00
Net debt / EBITDA0.74–
Interest coverage12.1×–
Current ratio2.508.88 (better)
Altman Z-score5.91 (better)3.14
Piotroski F-score8 (better)3
Dividends and buybacks
Buyback yield2.7%7.0% (better)
Shareholder yield2.7%7.0% (better)
Ownership
Held by institutions79.1%80.9%
Held by insiders12.2%17.6%
Insider net buying, 12 months$150K$546K (better)
Short interest, % of float3.9%4.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.